Mineralys Therapeutics, Inc. Insider Transactions
Mineralys Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Rodman David Malcom
Chief Medical Officer |
Sell | 2,966 @ $13.69 | $40.61 K | 120,086 | 04/14/2025 | 04/15/2025 | |
|
Rodman David Malcom
Chief Medical Officer |
Sell | 8,400 @ $14.83 | $124.57 K | 111,686 | 04/14/2025 | 04/15/2025 | |
|
Congleton Jon
CEO |
Sell | 15,319 @ $12.19 | $186.80 K | 862,289 | 04/11/2025 | 04/15/2025 | |
|
Levy Adam Scott
CFO and Secretary |
Sell | 10,757 @ $12.06 | $129.68 K | 215,340 | 04/11/2025 | 04/15/2025 | |
|
Rodman David Malcom
Chief Medical Officer |
Sell | 30,574 @ $15.00 | $458.54 K | 141,901 | 04/01/2025 | 04/03/2025 | |
|
Rodman David Malcom
Chief Medical Officer |
Sell | 2,791 @ $16.02 | $44.72 K | 139,110 | 04/01/2025 | 04/03/2025 | |
|
Rodman David Malcom
Chief Medical Officer |
Sell | 22,406 @ $16.77 | $375.75 K | 116,704 | 04/01/2025 | 04/03/2025 | |
|
Samsara BioCapital GP, LLC
10 percent owner |
Buy | 600,000 @ $13.50 | $8.10 M | 5,674,916 | 03/13/2025 | 03/17/2025 | |
|
AKKARAJU SRINIVAS
Director |
Buy | 600,000 @ $13.50 | $8.10 M | 5,674,916 | 03/13/2025 | 03/17/2025 | |
|
RA CAPITAL MANAGEMENT, L.P.
Director |
Buy | 1,296,296 @ $13.50 | $17.50 M | 4,280,051 | 03/13/2025 | 03/17/2025 | |
|
Levy Adam Scott
CFO and Secretary |
Sell | 10,657 @ $9.09 | $96.90 K | 226,197 | 01/13/2025 | 01/15/2025 | |
|
Levy Adam Scott
CFO and Secretary |
Sell | 100 @ $9.63 | $963 | 226,097 | 01/13/2025 | 01/15/2025 | |
|
Congleton Jon
CEO |
Sell | 18,333 @ $9.06 | $166.08 K | 877,608 | 01/13/2025 | 01/15/2025 | |
|
Rodman David Malcom
Chief Medical Officer |
Sell | 5,026 @ $15.00 | $75.40 K | 140,991 | 11/11/2024 | 11/12/2024 | |
|
Rodman David Malcom
Chief Medical Officer |
Sell | 25,482 @ $15.03 | $383.07 K | 135,974 | 11/06/2024 | 11/08/2024 | |
|
Levy Adam Scott
CFO and Secretary |
Sell | 10,757 @ $13.57 | $146.00 K | 236,854 | 10/11/2024 | 10/15/2024 | |
|
Congleton Jon
CEO |
Sell | 15,271 @ $13.52 | $206.43 K | 895,941 | 10/11/2024 | 10/15/2024 | |
|
Slingsby Brian Taylor
Director, 10 percent owner: |
Sell | 550,000 @ $13.05 | $7.18 M | 8,644,579 | 07/24/2024 | 07/26/2024 | |
|
Rodman David Malcom
Chief Medical Officer |
Sell | 525 @ $15.00 | $7.88 K | 102,873 | 07/16/2024 | 07/18/2024 | |
|
Levy Adam Scott
CFO and Secretary |
Sell | 10,757 @ $13.14 | $141.39 K | 247,611 | 07/11/2024 | 07/12/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Mineralys Therapeutics, Inc. FAQ's
The list of insiders at Mineralys Therapeutics, Inc. includes Levy Adam Scott, Congleton Jon, Samsara BioCapital GP, LLC, AKKARAJU SRINIVAS, RA CAPITAL MANAGEMENT, L.P., Rodman David Malcom.
Insiders have sold a total of 122.30 K Mineralys Therapeutics, Inc. shares in the last 12 months for a total of 1.62 M sold.
The following insiders have sold Mineralys Therapeutics, Inc. shares in the last 12 months: Levy Adam Scott ($227.55 K), Congleton Jon ($352.89 K), Rodman David Malcom ($1.04 M),
Insiders have purchased a total of 2.50 M Mineralys Therapeutics, Inc. shares in the last 12 months for a total of 33.70 M.
The following insiders have purchased Mineralys Therapeutics, Inc. shares in the last 12 months: Samsara BioCapital GP, LLC ($8.10 M), AKKARAJU SRINIVAS ($8.10 M), RA CAPITAL MANAGEMENT, L.P. ($17.50 M),